Price T Rowe Associates Inc Immatics N.V. Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Immatics N.V. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,639,562 shares of IMTX stock, worth $34 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,639,562
Previous 3,225,360
12.84%
Holding current value
$34 Million
Previous $33.9 Million
24.76%
% of portfolio
0.01%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding IMTX
# of Institutions
100Shares Held
76.8MCall Options Held
571KPut Options Held
210K-
Rtw Investments, LP New York, NY10MShares$93.5 Million1.94% of portfolio
-
Wellington Management Group LLP Boston, MA9.54MShares$89.2 Million0.02% of portfolio
-
Perceptive Advisors LLC New York, NY8.09MShares$75.6 Million2.72% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.43MShares$69.5 Million0.05% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$60.2 Million1.0% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $713M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...